Skip to main content
Fig. 3 | Genes and Environment

Fig. 3

From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Fig. 3

Survival analysis of ENCORI and GEPIA2 online databases, based on the expression level of NEAT1 in the BC and GC patients. a) Survival analysis by ENCORI online database revealed a not significant negative correlation between the expression level of NEAT1 in the BC patients and the survival rate of BC samples. b) GEPIA2 online survival analysis revealed that the high NEAT1 expression is correlated with the lower survival rate of BC samples and higher survival rate of GC patients, not significantly

Back to article page